Jolanda De Vries

Biography

 Jolanda de Vries is Professor at the Department of Tumor Immunology at the Radboud Institute for Molecular Life Sciences. Jolanda de Vries did her PhD at the Department of Dermatology of University Medical Centre Utrecht (The Netherlands) from 1991-1997. In 1997 she joined the Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc.  She was one of the pioneers to translate dendritic cell (DC) biology into potential clinical applications. The first clinical phase I/II studies in which patients were vaccinated with DCs loaded with tumor-specific peptides were initiated in 1997. She also developed a novel immuno-monitoring assay that is highly predictive for extended survival after vaccination with DCs. Her primary scientific interest continues along the line of DC-immunotherapy and in particular the migration and imaging of DC. 

Research Interest

 Oncology